|
|
|
|
| LEADER |
01590nam a2200241 u 4500 |
| 001 |
EB002001542 |
| 003 |
EBX01000000000000001164443 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Dialysis for the treatment of end stage kidney disease in indigenous patients in Canada
|h Elektronische Ressource
|b a review of clinical effectiveness
|
| 246 |
3 |
1 |
|a Dialysis for ESKD in indigenous patients
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2016, 6 December 2016
|
| 300 |
|
|
|a 1 PDF file (23 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report: peer-reviewed summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK424251
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a To supplement a CADTH optimal use project seeking to compare the clinical effectiveness of the various dialysis modalities, this Rapid Response report specifically examines the clinical effectiveness of in-centre and home-based peritoneal dialysis (PD) and hemodialysis (HD) for the treatment of end stage kidney disease (ESKD) in Indigenous Canadians. This report was reviewed by experts in nephrology and dialysis care, one of whom is Indigenous, and another who works with Indigenous populations
|